#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Cellular plasticity of pathogenic fungi during infection


Authors: Kenya E. Fernandes aff001;  Dee A. Carter aff001
Authors place of work: School of Life and Environmental Sciences and the Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia aff001
Published in the journal: Cellular plasticity of pathogenic fungi during infection. PLoS Pathog 16(6): e32767. doi:10.1371/journal.ppat.1008571
Category: Pearls
doi: https://doi.org/10.1371/journal.ppat.1008571

Introduction

A widespread trait amongst fungi is their ability to alter their morphology in response to environmental stimuli. The type and degree of alteration, which commonly includes changes in cell size and shape, can vary between strains and even between individual cells within genetically uniform populations, providing many levels of variation within species. As well as enhancing their ability to survive in different environmental niches, this variation plays an important role in the ability of human fungal pathogens to survive and cause disease in the host. Some well-known examples are the thermally dimorphic fungi, which grow as moulds at 22 °C–25 °C in the soil and covert into yeasts at 37 °C when in a mammalian host [1]. Some fungi, rather than switching between 2 distinct forms in different niches, produce a variety of forms in the host that appear to have roles in the infection process. This phenomenon has not been as extensively studied as thermal dimorphism but may be important for understanding disease progression and outcome. Here, we review selected examples of pathogenic fungi that produce distinct morphological forms when living in and on host tissues that may be linked to infection and virulence. Two genera, Candida and Malassezia, are highly adapted to the commensal lifestyle and can also become pathogenic, and 2 others, Coccidioides and Cryptococcus, have environmental components to their life cycle but show evidence of adaptation to life inside a host.

White-to-opaque and yeast-to-hyphae transitions in Candida albicans

C. albicans is a commensal of humans that colonises the mucosal surfaces of most healthy individuals but can cause life-threatening infections in immunocompromised hosts [2]. The ability to thrive in different niches within the host is crucial for survival, and C. albicans possesses an array of morphological forms that are thought to aid it in this process (Table 1; Fig 1A). During commensal growth, C. albicans exhibits a range of morphologies that appear to be suited to various host niches [3]. White, opaque, grey, and gastrointestinal-induced transition (GUT) yeast cell types have been described, and C. albicans can switch between these, enabling it to adapt rapidly to changes in its environment. White cells are smooth and round, whereas opaque cells are elongated, with more vacuoles and cell surface protuberances, and grey cells are the smallest cell type and are elongated with no protuberances [4, 5]. Opaque cells have been found to mate more efficiently than white cells and, along with grey cells, are more virulent and capable of faster proliferation on epithelial surfaces, whilst white cells are more virulent in systemic bloodstream infection models [68]. Opaque cells also possess increased resistance to macrophages and neutrophils because, unlike white cells, they do not secrete a chemoattractant, and it has been suggested that the switch to opaque cells may be a mechanism to escape the immune system [9]. GUT cells are morphologically similar to opaque cells but do not possess cell surface protuberances, are unable to mate, and seem to be specialised for commensalism in the mammalian gastrointestinal tract, displaying superior fitness to other cell types in models of this niche [10].

Fig. 1. Morphological switches and transitions during the fungal infection process.
Morphological switches and transitions during the fungal infection process.
(A) Yeast-to-hyphae-to-pseudohyphae transformations and switching between white, grey, opaque, and GUT yeast forms in C. albicans. (B) Reversible yeast-hyphae switching in Malassezia. (C) The spherule-endospore cycle, unique to Coccidioides infections. (D) Differentiation of regular yeast cells to produce various morphologically different forms in Cryptococcus. GUT, gastrointestional-induced transition.
Tab. 1. The variety of morphological forms produced by pathogenic fungi that may play a role during the infection process.
The variety of morphological forms produced by pathogenic fungi that may play a role during the infection process.

With host immunosuppression, C. albicans can become an opportunistic pathogen, and this is accompanied by transitions from the unicellular yeast form to hyphal and pseudohyphal cell types [3]. Candida hyphae are long, filamentous, and multicellular [11], whilst pseudohyphae are elongated ovals that have features of both yeasts and hyphae. Depending on environmental factors, these 3 cell types can either stably proliferate to maintain their cell type or transition to the other cell types, and the ability to do so is a crucial determinant of virulence in C. albicans. Hyphal and pseudohyphal forms are invasive and are thought to have an increased ability to penetrate into host tissues and internal organs and cause damage, whilst yeast cells may aid dissemination through the bloodstream because of their small size [15, 16]. Mutants that cannot interchange between these cell types are typically defective in infection models, and isolates taken from patients with disseminated candidiasis generally contain both yeast and hyphal forms [12, 13]. Biofilms, which are complex and densely packed communities of cells with increased resistance to host defences and antifungal drugs, also typically contain all 3 cell types [14].

Yeast-to-hyphae transition and pleomorphism in Malassezia spp.

Malassezia spp. are lipid-dependent yeasts that are a major component of the normal skin mycobiome of humans and other animals, although metagenomic sequencing studies have found Malassezia DNA in various terrestrial and marine habitats, suggesting some species may inhabit a wider ecological niche than was previously assumed [1719]. Under certain conditions that induce fungal overgrowth or through host immunocompromisation, commensal Malassezia species can become opportunistic pathogens, and cause a variety of dermatological conditions. In host tissues, Malassezia can reversibly switch between yeasts of around 8 μm in diameter and hyphae or pseudohyphae of 10–25 μm in length (Table 1; Fig 1B), resulting in a characteristic “spaghetti and meatballs” appearance in scrapings from infected skin or lesions [20]. The yeast form of Malassezia has many known virulence attributes, including the ability to either up-regulate or suppress the immune response [21]. Hyphal forms are difficult to produce in vivo and are therefore less well understood, but it is thought that they can penetrate keratinised skin cells, gaining access to deeper nutrient-rich layers where they can revert to the yeast form and proliferate to replace cells being shed at the epidermal surface [15]. Beyond these commonly known forms, considerable other variations in the morphology of Malassezia have been observed, including ovoid and cylindrical cells and hyphae of varying size [22] (Table 1). To date, these morphologies have received little attention, and they may play distinct and potentially important roles in infection.

Spherule formation and hyphal polymorphism in Coccidioides immitis and C. posadasii

C. immitis and C. posadasii are soil-dwelling pathogenic fungi that cause pulmonary infection via airborne arthroconidia, which can develop into life-threatening disseminated disease in at-risk individuals [23]. Although originally thought to be an accidental pathogen and opportunist, recent studies indicate that the infection of small animals such as bats and armadillos may form part of the life cycle of Coccidioides and that it has evolved specific adaptations for host interaction [24]. Central to its pathogenicity during human infection is the production of spherules and endospores. Spherules are formed from a gradual enlargement and transformation of inhaled arthroconidia into a structure that is typically 30–80 μm in diameter and contains around 100–300 endospores [25] (Table 1; Fig 1C). Upon rupture of the spherule, the endospores are released into host tissues, where each can produce hyphal growth or develop into a new spherule, repeating the growth cycle [26]. In addition to temperature and CO2 levels, there is evidence that the transition to spherules can be stimulated by contact with neutrophils, and reversion of arthroconidia to hyphal forms has occasionally been observed in infected lung cavities with no neutrophils [23]. Other, less well-characterised morphotypes have also been observed clinically, but their role in infection is not well understood (Table 1) [27, 28].

Variation in capsule and cell size in Cryptococcus

Cryptococcus neoformans and members of the C. gattii species complex are encapsulated yeasts that cause severe respiratory and cerebral disease, primarily amongst immunocompromised individuals [29]. Although the pathogenic Cryptococcus species are considered to be environmental fungi, adaptations for survival during interactions with environmental predators such as amoebae, insects, and other short-lived organisms are thought to explain their broad host range and possession of various pathogenic traits [30]. Cryptococcus cells are typically spherical and 4–7 μm in diameter, but during human infection, the appearance of forms of varying size is common (Table 1; Fig 1D). The polysaccharide capsule possessed by Cryptococcus cells is highly dynamic and undergoes substantial enlargement during human infection [31]. Cells with enlarged capsules have been shown to be more resistant to oxidative stress, antimicrobial peptides, and phagocytosis and are generally associated with more severe pathology [32]. Both C. neoformans and members of the C. gattii complex can produce highly enlarged “titan” cells, which are greater than 15 μm in diameter and have been seen to reach up to 100 μm. Titan cells have unique characteristics, including thickened cell walls, dense capsules, large vacuoles, and polyploidy [33]. These traits appear to contribute to survival in the host, with their capsular properties increasing resistance to oxidative, nitrosative, and other stresses and their massive size preventing phagocytosis and elimination by macrophages [34]. When replicating, titan cells produce regular-sized progeny; hence, they are always part of a heterogenous mixture of cell types [35].

At the other end of the spectrum, C. neoformans can produce “micro” cells, a subpopulation of cells that are smaller than 1 μm in diameter [36]. Whilst much less research has been done on micro cells, they are a cell type that has been seen during human infection, and it is thought that they may cross biological barriers more readily because of their small size, aiding dissemination of the pathogen to other body sites [37, 38]. Micro cells are seen in different C. neoformans varieties and genotypes but have not been observed in species of the C. gattii complex [39]. Recent studies have further identified cells with unusual, irregular morphologies in some Cryptococcus strains. These can be tapered and egg-shaped or elongated and of a more pseudohyphal form. Their presence in clinical populations has been associated with increased antifungal tolerance but decreased virulence, which suggests they may promote persistence in the host [38, 39]. Like titan cells, micro and irregular cell types always appear as part of a mix of different cell types.

Conclusions

Diverse fungal morphologies are increasingly being recognised as key traits associated with virulence, aiding pathogens in various ways, including adhesion to physiological barriers, dissemination through the body, and manipulation of host immune responses [40]. Whilst some morphological forms have well-characterised implications for virulence and pathogenesis, there is still much to learn about the capacity of fungi for morphogenesis during disease progression. This knowledge may ultimately help inform disease diagnosis and prognosis, with implications for treatment strategies.


Zdroje

1. Sil A, Andrianopoulos A. Thermally dimorphic human fungal pathogens—polyphyletic pathogens with a convergent pathogenicity trait. Cold Spring Harb Perspect Med. 2014;5(8): a019794. doi: 10.1101/cshperspect.a019794 PubMed Central PMCID: PMC4526722. 25384771

2. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62(1): 10–24. doi: 10.1099/jmm.0.045054–0

3. Noble SM, Gianetti BA, Witchley JN. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol. 2017;15(2): 96–108. doi: 10.1038/nrmicro.2016.157 PubMed Central PMCID: PMC5957277. 27867199

4. Anderson J, Mihalik R, Soll DR. Ultrastructure and antigenicity of the unique cell wall pimple of the Candida opaque phenotype. J Bacteriol. 1990;172(1): 224–35. doi: 10.1128/jb.172.1.224-235.1990 PubMed Central PMCID: PMC208422. 2403540

5. Bommanavar SB, Gugwad S, Malik N. Phenotypic switch: the enigmatic white-gray-opaque transition system of Candida albicans. J Oral Maxillofac Pathol. 2017;21(1): 82–6. doi: 10.4103/0973-029X.203781 PubMed Central PMCID: PMC5406825. 28479692

6. Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, Soll DR. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun. 1999;67(12): 6652–62. 10569787

7. Tao L, Du H, Guan G, Dai Y, Nobile CJ, Liang W, et al. Discovery of a "white-gray-opaque" tristable phenotypic switching system in Candida albicans: roles of non-genetic diversity in host adaptation. PLoS Biol. 2014;12(4): e1001830. doi: 10.1371/journal.pbio.1001830 PubMed Central PMCID: PMC3972085. 24691005

8. Xie J, Tao L, Nobile CJ, Tong Y, Guan G, Sun Y, et al. White-opaque switching in natural MTLa/alpha isolates of Candida albicans: evolutionary implications for roles in host adaptation, pathogenesis, and sex. PLoS Biol. 2013;11(3): e1001525. doi: 10.1371/journal.pbio.1001525 PubMed Central PMCID: PMC3608550. 23555196

9. Sasse C, Hasenberg M, Weyler M, Gunzer M, Morschhauser J. White-opaque switching of Candida albicans allows immune evasion in an environment-dependent fashion. Eukaryot Cell. 2013;12(1): 50–8. doi: 10.1128/EC.00266-12 PubMed Central PMCID: PMC3535852. 23125350

10. Pande K, Chen C, Noble SM. Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism. Nat Genet. 2013;45(9): 1088–91. doi: 10.1038/ng.2710 PubMed Central PMCID: PMC3758371. 23892606

11. Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12(7): 317–24. doi: 10.1016/j.tim.2004.05.008 15223059

12. Di Carlo P, Di Vita G, Guadagnino G, Cocorullo G, D'Arpa F, Salamone G, et al. Surgical pathology and the diagnosis of invasive visceral yeast infection: two case reports and literature review. World J Emerg Surg. 2013;8(1): 38. doi: 10.1186/1749-7922-8-38 PubMed Central PMCID: PMC3849356. 24067049

13. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell. 1997;90(5): 939–49. doi: 10.1016/s0092-8674(00)80358-x 9298905

14. Desai JV, Mitchell AP. Candida albicans biofilm development and its genetic control. Microbiol Spectr. 2015;3(3): MB-0005–2014. doi: 10.1128/microbiolspec.MB-0005-2014 PubMed Central PMCID: PMC4507287. 26185083

15. Brand A. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol. 2012;2012: 517529. doi: 10.1155/2012/517529 PubMed Central PMCID: PMC3216317. 22121367

16. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2): 119–28. doi: 10.4161/viru.22913 PubMed Central PMCID: PMC3654610. 23302789

17. Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, Boekhout T, Dawson TL Jr. Malassezia ecology, pathophysiology, and treatment. Med Mycol. 2018;56(suppl_1): S10–S25. doi: 10.1093/mmy/myx134 29538738.

18. Amend A. From dandruff to deep-sea vents: Malassezia-like fungi are ecologically hyper-diverse. PLoS Pathog. 2012;10(8): e1004277. doi: 10.1371/journal.ppat.1004277.g001

19. Richards TA, Jones MD, Leonard G, Bass D. Marine fungi: their ecology and molecular diversity. Ann Rev Mar Sci. 2012;4: 495–522. doi: 10.1146/annurev-marine-120710-100802 22457985

20. Ashbee HR. Update on the genus Malassezia. Med Mycol. 2007;45(4): 287–303. doi: 10.1080/13693780701191373 17510854.

21. Ashbee HR, Evans EG. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 2002;15(1): 21–57. doi: 10.1128/CMR.15.1.21-57.2002 11781265; PubMed Central PMCID: PMC118058.

22. Midgley G. Morphological variation in Malassezia and its significance in pityriasis versicolor. In: Bossche H, Odds FC, Kerridge D, editors. Dimorphic fungi in biology and medicine. Boston, MA: Springer; 1993. p. 267–77.

23. Kirkland TN, Fierer J. Coccidioides immitis and posadasii; a review of their biology, genomics, pathogenesis, and host immunity. Virulence. 2018;9(1): 1426–35. doi: 10.1080/21505594.2018.1509667 30179067; PubMed Central PMCID: PMC6141143.

24. Del Rocio Reyes-Montes M, Perez-Huitron MA, Ocana-Monroy JL, Frias-De-Leon MG, Martinez-Herrera E, Arenas R, et al. The habitat of Coccidioides spp. and the role of animals as reservoirs and disseminators in nature. BMC Infect Dis. 2016;16(1): 550. doi: 10.1186/s12879-016-1902-7 27724885

25. Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007;45(1): 26–30. doi: 10.1128/JCM.02230-06 PubMed Central PMCID: PMC1828958. 17108067

26. Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, et al. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev. 2013;26(3): 505–25. doi: 10.1128/CMR.00005-13 PubMed Central PMCID: PMC3719491. 23824371

27. Munoz-Hernandez B, Martinez-Rivera MA, Palma-Cortes G, Manjarrez E. Innovation of the parasitic cycle of Coccidioides spp. In: Shah MM, editor. Parasitology: InTech; 2012.

28. Munoz-Hernandez B, Palma-Cortes G, Cabello-Gutierrez C, Martinez-Rivera MA. Parasitic polymorpism of Coccidioides spp. BMC Infect. 2014;14: 213.

29. Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014;4(7): a019760. doi: 10.1101/cshperspect.a019760 PubMed Central PMCID: PMC4066639. 24985132

30. Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA. 2001;98(26): 15245–50. doi: 10.1073/pnas.261418798 11742090

31. O'Meara TR, Alspaugh JA. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev. 2012;25(3): 387–408. doi: 10.1128/CMR.00001-12 PubMed Central PMCID: PMC3416491. 22763631

32. Zaragoza O. Basic principles of the virulence of Cryptococcus. Virulence. 2019;10(1): 490–501. doi: 10.1080/21505594.2019.1614383 PubMed Central PMCID: PMC6550552. 31119976

33. Zaragoza O, Nielsen K. Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol. 2013;16(4): 409–13. doi: 10.1016/j.mib.2013.03.006 PubMed Central PMCID: PMC3723695. 23588027

34. Okagaki LH, Nielsen K. Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. Eukaryot Cell. 2012;11(6): 820–6. doi: 10.1128/EC.00121-12 PubMed Central PMCID: PMC3370461. 22544904

35. Gerstein AC, Fu MS, Mukaremera L, Li Z, Ormerod KL, Fraser JA, et al. Polyploid titan cells produce haploid and aneuploid progeny to promote stress adaptation. mBio. 2015;6(5): e01340–15. doi: 10.1128/mBio.01340-15 PubMed Central PMCID: PMC4620463. 26463162

36. Zaragoza O. Multiple disguises for the same party: the concepts of morphogenesis and phenotypic variations in Cryptococcus neoformans. Front Microbiol. 2011;2: 181. doi: 10.3389/fmicb.2011.00181 PubMed Central PMCID: PMC3167222. 21922016

37. Feldmesser M, Kress Y, Casadevall A. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology. 2001;147(8): 2355–65. doi: 10.1099/00221287-147-8-2355 11496012

38. Fernandes KE, Brockway A, Haverkamp M, Cuomo CA, van Ogtrop F, Perfect JR, et al. Phenotypic variability correlates with clinical outcome in Cryptococcus isolates obtained from Botswanan HIV/AIDS patients. mBio. 2018;9(5): e02016–18. doi: 10.1128/mBio.02016-18 PubMed Central PMCID: PMC6199498. 30352938

39. Fernandes KE, Dwyer C, Campbell LT, Carter DA. Species in the Cryptococcus gattii complex differ in capsule and cell size following growth under capsule-inducing conditions. mSphere. 2016;1(6): e00350–16. doi: 10.1128/mSphere.00350-16 PubMed Central PMCID: PMC5196034. 28066814

40. Hewitt SK, Foster DS, Dyer PS, Avery SV. Phenotypic heterogeneity in fungi: importance and methodology. Fungal Biology Reviews. 2016;30(4): 176–84. doi: 10.1016/j.fbr.2016.09.002


Článek vyšel v časopise

PLOS Pathogens


2020 Číslo 6
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Důležitost adherence při depresivním onemocnění
nový kurz
Autoři: MUDr. Eliška Bartečková, Ph.D.

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková, Ph.D.

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Multidisciplinární zkušenosti u pacientů s diabetem
Autoři: Prof. MUDr. Martin Haluzík, DrSc., prof. MUDr. Vojtěch Melenovský, CSc., prof. MUDr. Vladimír Tesař, DrSc.

Všechny kurzy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#